Hepatic steatosis as measured by the computed attenuation parameter predicts fibrosis in long-term methotrexate use.

Tomaszewski, Marcel; Dahiya, Monica; Mohajerani, Seyed Amir; Punja, Hanaa; Ko, Hin Hin; Sun, Muxin; Ramji, Alnoor

Tomaszewski, Marcel; Dahiya, Monica; Mohajerani, Seyed Amir; Punja, Hanaa; Ko, Hin Hin; Sun, Muxin; Ramji, Alnoor.

Afiliação

Tomaszewski M; Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Dahiya M; Faculty of Medicine, University of Alberta., Edmonton, Alberta, Canada.
Mohajerani SA; Saint Paul's Hospital, Gastrointestinal Research Institute, Vancouver, British Columbia, Canada.
Punja H; Department of Biology, University of British Columbia, Vancouver, British Columbia, Canada.
Ko HH; Clinical Associate Professor of Medicine, Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Sun M; Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Ramji A; Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Can Liver J ; 4(4): 370-380, 2021.

Article em En | MEDLINE | ID: mdl-35989896

Palavras-chave

liver diseases; methotrexate; psoriasis; psoriatic arthritis; rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Can Liver J Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google